Brooklyn Fi, LLC Sellas Life Sciences Group, Inc. Transaction History
Brooklyn Fi, LLC
- $18.3 Billion
- Q4 2024
A detailed history of Brooklyn Fi, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Brooklyn Fi, LLC holds 594,919 shares of SLS stock, worth $749,597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
594,919Holding current value
$749,597% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SLS
# of Institutions
38Shares Held
6.68MCall Options Held
1.73MPut Options Held
95.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.89 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.5 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$924,2670.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$611,4990.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$542,2630.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $25.9M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...